Published in Vaccine Weekly, April 21st, 1997
In a two-step process, tumor cells removed from a patient are first modified in the laboratory with a combination of cytokines to enhance the expression of tumor antigens and immune-activating molecules needed to generate the body's immune response.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.